Owner Pfizer Inc.

Inventors Claffey, Michelle Marie; Dounay, Amy Beth; Gan, Xinmin; Hayward, Matthew Merrill; Rong, Suobao; Tuttle, Jamison Bryce; Verhoest, Patrick Robert

Agent Shelston IP

Pub. Number AU-A-2010261399

PCT Pub. Number WO2010/146488

Priority 61/218,149 18.06.09 US; 61/334,389 13.05.10 US

Filing date 26 May 2010

Wipo publication date 23 December 2010

C07D 215/60 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4375 (2006.01)

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or